Supernus Pharmaceuticals Wednesday announced that it has filed Form S-1 with the Securities and Exchange Commission or the SEC revealing the pricing of its initial public offering for 5,769,000 shares of common stock.
The company revealed that it anticipates to price the initial public offering to be between $12.00 and $14.00 per share of common stock.
The company further added that it has granted the underwriters an option to purchase up to 865,350 additional shares of common stock to cover over-allotments.
The company stated that itsd shares would be listed on the Nasdaq Global Market under the symbol "SUPN."
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org